From the development of COVID-19 vaccines to testing kits, publicly-traded healthcare outfits are one group of companies that have witnessed a remarkable surge in shares over the past two months. Consequently, the success of these companies has influenced its C-suite, minting a new billionaire, and boosting the fortunes of at least nine more.
